Genetic ancestry and risk of mortality among U.S. latinas with breast cancer

Cancer Research

Volumn 73, Issue 24, 2013, Pages 7243-7253

  Fejerman, Laura ^a   Hu, Donglei ^a   Huntsman, Scott ^a   John, Esther M ^c,d   Stern, Mariana C ^e   Haiman, Christopher A ^e   Pérez Stable, Eliseo J ^a,b   Ziv, Elad ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; ETHNIC GROUP; FAMILY HISTORY; FEMALE; GENETIC ANCESTRY; GENETIC ASSOCIATION; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL STATUS; SURVIVAL PREDICTION;

BREAST NEOPLASMS; CALIFORNIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84891275904     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2014     Document Type: Article

References (49)

1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: Update 2006.CA Cancer J Clin 2006;56:168-83.
2. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9:R28.
3. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003; 163:49-56.
4. Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: A meta-analysis of 14 studies involving over 10,000 African- American and 40,000 White American patients with carcinoma of the breast. Cancer 2002;94:2844-54.
5. Sprague BL, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer 2011;117: 1542-51.
6. Newman LA, Griffith KA, Jatoi I, Simon MS, Crowe JP, Colditz GA. Meta-analysis of survival in African American and white American patients with breast cancer: Ethnicity compared with socioeconomic status. J Clin Oncol 2006;24:1342-9.
7. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94: 490-6.
8. Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: A population-based study. Cancer Detect Prev 1999;23:463-73.
9. Via M, Gignoux CR, Roth LA, Fejerman L, Galanter J, Choudhry S, et al. History shaped the geographic distribution of genomic admixture on the island of Puerto Rico. PLoS One 2011;6:e16513.
10. Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez- Lopez JC, Uribe-Figueroa L, Contreras A, et al. Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci U S A 2009;106: 8611-6.
11. Parra EJ, Kittles RA, Shriver MD. Implications of correlations between skin color and genetic ancestry for biomedical research. Nat Genet 2004;36:S54-60.
12. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009;30:69-78.
13. Fejerman L, Chen GK, Eng C, Huntsman S, Hu D, Williams A, et al. Admixture mapping identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet 2012;21: 1907-17.
14. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez- Stable E, et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res 2008;68:9723-8.
15. Fejerman L, Romieu I, John EM, Lazcano-Ponce E, Huntsman S, Beckman KB, et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomarkers Prev 2010;19:1074-82.
16. Hartman M, Lindstrom L, Dickman PW, Adami HO, Hall P, Czene K. Is breast cancer prognosis inherited Breast Cancer Res 2007;9: R39.
17. Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K. Familial concordance in cancer survival: A Swedish population-based study. Lancet Oncol 2007;8:1001-6.
18. John EM, Horn-Ross PL, Koo J. Lifetime physical activity and breast cancer risk in a multiethnic population: The San Francisco Bay area breast cancer study. Cancer Epidemiol Biomarkers Prev 2003;12: 1143-52.
19. John EM, Phipps AI, Davis A, Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomarkers Prev 2005;14:2905-13.
20. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: An infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6: R375-89.
21. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703-11.
22. Keegan TH, John EM, Fish KM, Alfaro-Velcamp T, Clarke CA, Gomez SL. Breast cancer incidence patterns among California Hispanic women: Differences by nativity and residence in an enclave. Cancer Epidemiol Biomarkers Prev 2010;19:1208-18.
23. Webster TF, Hoffman K, Weinberg J, Vieira V, Aschengrau A. Community- and individual-level socioeconomic status and breast cancer risk: Multilevel modeling on Cape Cod, Massachusetts. Environ Health Perspect 2008;116:1125-9.
24. Price AL, Tandon A, Patterson N, Barnes KC, Rafaels N, Ruczinski I, et al. Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet 2009;5:e1000519.
25. StataCorp. Stata Statistical Software: Release 12.1. College Station, TX: StataCorp LP; 2011.
26. Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med 1991;10: 585-98.
27. Campbell JB. Breast cancer-race, ethnicity, and survival: A literature review. Breast Cancer Res Treat 2002;74:187-92.
28. Le Marchand L. Ethnic variation in breast cancer survival: A review. Breast Cancer Res Treat 1991;18 Suppl 1:S119-26.
29. Austin LT, Ahmad F, McNally MJ, Stewart DE. Breast and cervical cancer screening in Hispanic women: A literature review using the health belief model. Womens Health Issues 2002;12:122-8.
30. Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, et al. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 2011;117: 180-9.
31. Bickell NA, Wang JJ, Oluwole S, Schrag D, Godfrey H, Hiotis K, et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol 2006;24:1357-62.
32. Coughlin SS, Uhler RJ. Breast and cervical cancer screening practices among Hispanic women in the United States and Puerto Rico, 1998- 1999. Prev Med 2002;34:242-51.
33. Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126: 529-37.
34. McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer 2008;99:1763-8.
35. Masuda N, Sagara Y, Kinoshita T, Iwata H, Nakamura S, Yanagita Y, et al. Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): A double-blind, randomised phase 3 trial. Lancet Oncol 2012;13: 345-52.
36. Chakraborty S, Smith L, Ganti AK, Bonthu N, Shimizhu T, Batra SK. Breast cancer survival of Hispanic women in the USA is influenced by country of origin. Asia Pac J Clin Oncol 2013 Apr 1. [Epub ahead of print].
37. Long JR, Kataoka N, Shu XO, Wen W, Gao YT, Cai Q, et al. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. Cancer Epidemiol Biomarkers Prev 2006;15:2115-22.
38. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q, et al. Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 2005;65:5015-9.
39. Deming SL, Ren Z, Wen W, Shu XO, Cai Q, Gao YT, et al. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: A report from the Shanghai Breast Cancer Study. Breast Cancer Res Treat 2007;104:309-19.
40. Zhang X, Shu XO, Cai Q, Ruan Z, Gao YT, Zheng W. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Clin Cancer Res 2006;12:6037-42.
41. Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, Karn T, et al. The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012;21:3926-39.
42. Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002;62:3052-7.
43. Shu XO, Long J, Lu W, Li C, Chen WY, Delahanty R, et al. Novel genetic markers of breast cancer survival identified by a genome-wide association study. Cancer Res 2012;72:1182-9.
44. Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, et al. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptornegative breast cancer survival. J Natl Cancer Inst 2010;102: 650-62.
45. Rafiq S, Tapper W, Collins A, Khan S, Politopoulos I, Gerty S, et al. Identification of inherited genetic variations influencing prognosis in early-onset breast cancer. Cancer Res 2013;73:1883-91.
46. Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, Caporaso NE, et al. A genome-wide association study of prognosisin breast cancer. Cancer Epidemiol Biomarkers Prev 2010;19: 1140-3.
47. Gamazon ER, Pinto N, Konkashbaev A, Im HK, Diskin SJ, London WB, et al. Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival. J Natl Cancer Inst 2013;105: 302-9.
48. Yang JJ, Cheng C, Devidas M, Cao X, Fan Y, Campana D, et al. Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia. Nat Genet 2011;43:237-41.
49. O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010;16:6100-10.